WINNIPEG, Sept. 7, 2011 /CNW/ - IMRIS Inc. (NASDAQ: IMRS) (TSX: IM)
("IMRIS" or the "Company") today announced the sale of IMRISneuro and
an iCT system to Duke Medicine ("Duke"), located in Durham, North
Carolina. IMRIS previously announced this as a sale to a confidential
customer on August 24, 2011.
The installation at Duke will include an IMRISneuro system delivering on
demand intraoperative MR imaging and an iCT system that will provide
intraoperative computed tomography imaging capabilities.
IMRIS (NASDAQ: IMRS) (TSX: IM) is a global leader in providing image
guided therapy solutions. These solutions feature fully integrated
surgical and interventional suites that incorporate magnetic resonance,
fluoroscopy and computed tomography to deliver on demand imaging during
procedures. The Company's systems serve the neurosurgical,
cardiovascular and neurovascular markets and have been selected by
leading medical institutions around the world.
SOURCE IMRIS Inc.
For further information:
Director Investor Relations & Corporate Communications